Literature DB >> 3153278

A review of drug prescribing in children with end-stage renal failure.

R S Trompeter1.   

Abstract

This review provides a guideline for the prescribing of drugs in children with end-stage renal failure. The altered physiology of renal failure affects the metabolism of most pharmacological agents and modification of the drug dosage or extension of the prescribed drug interval become necessary with declining glomerular filtration rate (GFR). Most dose adjustments are dependent on a knowledge of renal function since GFR is inversely proportioned to the elimination rate constant of a drug. The details of drugs listed by generic name are those commonly used in paediatric practice, and the recommendations for dose adjustments are related to a reduction in GFR and not to body mass. Familiarization with the normal dose prescription of any drug used in paediatric practice is therefore necessary when referring to the table.

Entities:  

Mesh:

Year:  1987        PMID: 3153278     DOI: 10.1007/bf00849293

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  Estimation of glomerular filtration rate from plasma creatinine concentration in children.

Authors:  R Counahan; C Chantler; S Ghazali; B Kirkwood; F Rose; T M Barratt
Journal:  Arch Dis Child       Date:  1976-11       Impact factor: 3.791

2.  Plasma creatinine and urea concentration in children: normal values for age and sex.

Authors:  G J Schwartz; G B Haycock; A Spitzer
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

3.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.

Authors:  P R Gwilt; D Perrier
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

6.  Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.

Authors:  P Somani; R S Shapiro; H Stockard; J T Higgins
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

7.  A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies.

Authors:  M J Keating; G P Bodey; M Valdivieso; V Rodriguez
Journal:  Medicine (Baltimore)       Date:  1979-03       Impact factor: 1.889

8.  The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.

Authors:  W M Bennett; C E Plamp; D N Gilbert; R A Parker; G A Porter
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

  8 in total
  4 in total

Review 1.  Drug dosage in children with reduced renal function.

Authors:  Markus Daschner
Journal:  Pediatr Nephrol       Date:  2005-08-23       Impact factor: 3.714

Review 2.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 3.  Management of acute renal failure.

Authors:  A Bagga
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

4.  Sensorineural hearing loss in patients reaching chronic renal failure in childhood.

Authors:  M L Mancini; L Dello Strologo; P M Bianchi; L Tieri; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.